Physician profile
Erin E Carlson
NPI 1174528608
$765.05
in general payments reported to CMS, 2019-2025
11 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.31 · 2021: $110 · 2022: $78.84 · 2023: $65.28 · 2024: $147 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $193.40 | 2021-2024 | Myday Contact Lens |
| Alcon Vision LLC | $185.07 | 2019-2025 | Clareon, Eysuvis |
| Biotissue Holdings INC. | $158.72 | 2025 | |
| Oyster Point Pharma, INC. | $57.74 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $42.70 | 2022-2023 | Acuvue |
| Rxsight INC | $34.53 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Harrow Eye, LLC | $23.60 | 2025 | Vevye |
| Abbvie INC. | $21.51 | 2023 | Durysta |
| Sun Pharmaceutical Industries INC. | $16.66 | 2024 | |
| Novartis Pharmaceuticals Corporation | $15.82 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $15.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.